Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment

BACKGROUND: Adoptive immunotherapy with cytotoxic T lymphocytes (CTL) represents an alternative approach to treating solid tumors. Ideally, this would confer long-term protection against tumor. We previously demonstrated that in vitro-generated tumor-specific CTL from the ovalbumin (OVA)-specific OT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathe, Oliver F, Dalyot-Herman, Nava, Malek, Thomas R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183847/
https://www.ncbi.nlm.nih.gov/pubmed/12882650
http://dx.doi.org/10.1186/1471-2407-3-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183847/
https://www.ncbi.nlm.nih.gov/pubmed/12882650
http://dx.doi.org/10.1186/1471-2407-3-21

Ejemplares similares